We are studying the safety and effectiveness of Ravulizumab in children and adolescents with NMOSD. This trial aims to see how it affects their neurological function and overall quality of life.
Health conditions and diseases that the clinical trial is designed to study and treat.
Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare autoimmune disorder that affects the central nervous system, particularly the optic nerves and spinal cord, leading to symptoms such as vision loss, weakness, and sensory disturbances.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
